Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
RELX plc ( (GB:REL) ) has issued an announcement.
RELX plc announced the purchase of 126,446 of its own ordinary shares through JP Morgan Securities plc, which will be held as treasury shares. This transaction is part of a broader share buyback program, with the company having purchased over 25 million shares since January 2025. The move is likely aimed at optimizing capital structure and returning value to shareholders, potentially impacting the company’s stock price and market perception.
The most recent analyst rating on (GB:REL) stock is a Buy with a £42.75 price target. To see the full list of analyst forecasts on RELX plc stock, see the GB:REL Stock Forecast page.
Spark’s Take on GB:REL Stock
According to Spark, TipRanks’ AI Analyst, GB:REL is a Outperform.
RELX plc’s strong financial performance and positive earnings call sentiment are the most significant factors driving the overall stock score. The technical analysis presents some caution with bearish momentum, and the valuation suggests the stock may be expensive. The proactive share buyback program contributes positively, indicating confidence in financial stability and commitment to shareholder value.
To see Spark’s full report on GB:REL stock, click here.
More about RELX plc
RELX plc operates in the information and analytics industry, providing data-driven insights and analytics to professional and business customers across various sectors, including science, healthcare, legal, risk, and business. The company focuses on delivering innovative solutions that enhance decision-making and efficiency for its clients.
Average Trading Volume: 3,682,165
Technical Sentiment Signal: Buy
Current Market Cap: £72.14B
See more data about REL stock on TipRanks’ Stock Analysis page.